Increased interleukin-17 in the cerebrospinal fluid in sporadic Creutzfeldt-Jakob disease: A case-control study of rapidly progressive dementia

Journal of Neuroinflammation

Volumn 10, Issue , 2013, Pages

  Fujita, Koji ^a   Matsui, Naoko ^a   Takahashi, Yukitoshi ^b   Iwasaki, Yasushi ^c,d   Yoshida, Mari ^c   Yuasa, Tatsuhiko ^e   Izumi, Yuishin ^a   Kaji, Ryuji ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b SHIZUOKA INSTITUTE OF EPILEPSY AND NEUROLOGICAL DISORDERS   (Japan)

^c AICHI MEDICAL UNIVERSITY   (Japan)

^d Oyamada Memorial Spa Hospital   (Japan)

^e Kamagaya General Hospital   (Japan)

Author keywords

Creutzfeldt Jakob disease; Cytokines; Inflammation; Interleukin 17; Neurodegeneration

Indexed keywords

CCL1 CHEMOKINE; FIBROBLAST GROWTH FACTOR 2; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; PROTEIN 14 3 3; RANTES; TAU PROTEIN; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; AUTOIMMUNE ENCEPHALITIS; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE DURATION; ENCEPHALITIS; FEMALE; HUMAN; MALE; MIDDLE AGED; NEUROLOGIC DISEASE; NEUROPATHOLOGY; PROTEIN ANALYSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SPORADIC CREUTZFELDT JAKOB DISEASE; VERY ELDERLY;

AGED; CASE-CONTROL STUDIES; CREUTZFELDT-JAKOB SYNDROME; DEMENTIA; DISEASE PROGRESSION; FEMALE; HUMANS; INTERLEUKIN-17; MALE;

EID: 84887391012     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-10-135     Document Type: Article

References (34)

1. Puoti G, Bizzi A, Forloni G, Safar JG, Tagliavini F, Gambetti P. Sporadic human prion diseases: molecular insights and diagnosis. Lancet Neurol 2012, 11:618-628. 10.1016/S1474-4422(12)70063-7, 22710755.
2. Fujita K, Yuasa T, Takahashi Y, Tanaka K, Hashiguchi S, Adachi K, Izumi Y, Kaji R. Detection of anti-glutamate receptor ε{lunate}2 and anti-N-methyl-D-aspartate receptor antibodies in a patient with sporadic Creutzfeldt-Jakob disease. J Neurol 2012, 259:985-988. 10.1007/s00415-011-6291-7, 22057403.
3. Fujita K, Yuasa T, Takahashi Y, Tanaka K, Sako W, Koizumi H, Iwasaki Y, Yoshida M, Izumi Y, Kaji R. Antibodies to N-methyl-D-aspartate glutamate receptors in Creutzfeldt-Jakob disease patients. J Neuroimmunol 2012, 251:90-93. 10.1016/j.jneuroim.2012.06.010, 22809875.
4. Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol 2006, 147(Suppl 1):232-240.
5. Burwinkel M, Riemer C, Schwarz A, Schultz J, Neidhold S, Bamme T, Baier M. Role of cytokines and chemokines in prion infections of the central nervous system. Int J Dev Neurosci 2004, 22:497-505. 10.1016/j.ijdevneu.2004.07.017, 15465279.
6. Tamgüney G, Giles K, Glidden DV, Lessard P, Wille H, Tremblay P, Groth DF, Yehiely F, Korth C, Moore RC, Tatzelt J, Rubinstein E, Boucheix C, Yang X, Stanley P, Lisanti MP, Dwek RA, Rudd PM, Moskovitz J, Epstein CJ, Cruz TD, Kuziel WA, Maeda N, Sap J, Ashe KH, Carlson GA, Tesseur I, Wyss-Coray T, Mucke L, Weisgraber KH, et al. Genes contributing to prion pathogenesis. J Gen Virol 2008, 89:1777-1788. 10.1099/vir.0.2008/001255-0, 2828448, 18559949.
7. Tribouillard-Tanvier D, Striebel JF, Peterson KE, Chesebro B. Analysis of protein levels of 24 cytokines in scrapie agent-infected brain and glial cell cultures from mice differing in prion protein expression levels. J Virol 2009, 83:11244-11253. 10.1128/JVI.01413-09, 2772806, 19710140.
8. Sharief MK, Green A, Dick JP, Gawler J, Thompson EJ. Heightened intrathecal release of proinflammatory cytokines in Creutzfeldt-Jakob disease. Neurology 1999, 52:1289-1291. 10.1212/WNL.52.6.1289, 10214763.
9. Van Everbroeck B, Dewulf E, Pals P, Lübke U, Martin JJ, Cras P. The role of cytokines, astrocytes, microglia and apoptosis in Creutzfeldt-Jakob disease. Neurobiol Aging 2002, 23:59-64. 10.1016/S0197-4580(01)00236-6, 11755020.
10. Stoeck K, Bodemer M, Ciesielczyk B, Meissner B, Bartl M, Heinemann U, Zerr I. Interleukin 4 and interleukin 10 levels are elevated in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. Arch Neurol 2005, 62:1591-1594. 10.1001/archneur.62.10.1591, 16216944.
11. Stoeck K, Bodemer M, Zerr I. Pro- and anti-inflammatory cytokines in the CSF of patients with Creutzfeldt-Jakob disease. J Neuroimmunol 2006, 172:175-181. 10.1016/j.jneuroim.2005.10.008, 16330103.
12. Korn T, Bettelli E, Oukka M, Kuchroo VK. IL-17 and Th17 cells. Annu Rev Immunol 2009, 27:485-517. 10.1146/annurev.immunol.021908.132710, 19132915.
13. World Health Organization Global Surveillance, Diagnosis and Therapy of Human Transmissible Spongiform Encephalopathies: Report of a WHO Consultation 1998, Geneva, World Health Organization.
14. Kitamoto T, Shin RW, Doh-ura K, Tomokane N, Miyazono M, Muramoto T, Tateishi J. Abnormal isoform of prion proteins accumulates in the synaptic structures of the central nervous system in patients with Creutzfeldt-Jakob disease. Am J Pathol 1992, 140:1285-1294. 1886543, 1351366.
15. Kitamoto T, Ohta M, Doh-ura K, Hitoshi S, Terao Y, Tateishi J. Novel missense variants of prion protein in Creutzfeldt-Jakob disease or Gerstmann-Sträussler syndrome. Biochem Biophys Res Commun 1993, 191:709-714. 10.1006/bbrc.1993.1275, 8461023.
16. Satoh K, Tobiume M, Matsui Y, Mutsukura K, Nishida N, Shiga Y, Eguhchi K, Shirabe S, Sata T. Establishment of a standard 14-3-3 protein assay of cerebrospinal fluid as a diagnostic tool for Creutzfeldt-Jakob disease. Lab Invest 2010, 90:1637-1644. 10.1038/labinvest.2009.68, 20697380.
17. Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H. 14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan. Cell Mol Neurobiol 2006, 26:45-52. 10.1007/s10571-006-9370-z, 16633900.
18. Iwasaki Y, Hashizume Y, Yoshida M, Kitamoto T, Sobue G. Neuropathologic characteristics of brainstem lesions in sporadic Creutzfeldt-Jakob disease. Acta Neuropathol 2005, 109:557-566. 10.1007/s00401-005-0981-0, 15933870.
19. Shimizu S, Hoshi K, Muramoto T, Homma M, Ironside JW, Kuzuhara S, Sato T, Yamamoto T, Kitamoto T. Creutzfeldt-Jakob disease with florid-type plaques after cadaveric dura mater grafting. Arch Neurol 1999, 56:357-362. 10.1001/archneur.56.3.357, 10190828.
20. Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H. Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 1999, 46:224-233. 10.1002/1531-8249(199908)46:2<224::AID-ANA12>3.0.CO;2-W, 10443888.
21. Tzartos JS, Friese MA, Craner MJ, Palace J, Newcombe J, Esiri MM, Fugger L. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am J Pathol 2008, 172:146-155. 10.2353/ajpath.2008.070690, 2189615, 18156204.
22. Komiyama Y, Nakae S, Matsuki T, Nambu A, Ishigame H, Kakuta S, Sudo K, Iwakura Y. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006, 177:566-573.
23. Tsutsui S, Hahn JN, Johnson TA, Ali Z, Jirik FR. Absence of the cellular prion protein exacerbates and prolongs neuroinflammation in experimental autoimmune encephalomyelitis. Am J Pathol 2008, 173:1029-1041. 10.2353/ajpath.2008.071062, 2543071, 18815152.
24. Ingram RJ, Isaacs JD, Kaur G, Lowther DE, Reynolds CJ, Boyton RJ, Collinge J, Jackson GS, Altmann DM. A role of cellular prion protein in programming T-cell cytokine responses in disease. FASEB J 2009, 23:1672-1684. 10.1096/fj.08-116087, 19204074.
25. Kang Z, Altuntas CZ, Gulen MF, Liu C, Giltiay N, Qin H, Liu L, Qian W, Ransohoff RM, Bergmann C, Stohlman S, Tuohy VK, Li X. Astrocyte-restricted ablation of interleukin-17-induced Act1-mediated signaling ameliorates autoimmune encephalomyelitis. Immunity 2010, 32:414-425. 10.1016/j.immuni.2010.03.004, 3073618, 20303295.
26. Yan Y, Ding X, Li K, Ciric B, Wu S, Xu H, Gran B, Rostami A, Zhang GX. CNS-specific therapy for ongoing EAE by silencing IL-17 pathway in astrocytes. Mol Ther 2012, 20:1338-1348. 10.1038/mt.2012.12, 3392982, 22434134.
27. Kawanokuchi J, Shimizu K, Nitta A, Yamada K, Mizuno T, Takeuchi H, Suzumura A. Production and functions of IL-17 in microglia. J Neuroimmunol 2008, 194:54-61. 10.1016/j.jneuroim.2007.11.006, 18164424.
28. Ishizu T, Osoegawa M, Mei FJ, Kikuchi H, Tanaka M, Takakura Y, Minohara M, Murai H, Mihara F, Taniwaki T, Kira J. Intrathecal activation of the IL-17/IL-8 axis in opticospinal multiple sclerosis. Brain 2005, 128:988-1002. 10.1093/brain/awh453, 15743872.
29. Thackray AM, McKenzie AN, Klein MA, Lauder A, Bujdoso R. Accelerated prion disease in the absence of interleukin-10. J Virol 2004, 78:13697-13707. 10.1128/JVI.78.24.13697-13707.2004, 533935, 15564479.
30. Mabbott NA, Williams A, Farquhar CF, Pasparakis M, Kollias G, Bruce ME. Tumor necrosis factor alpha-deficient, but not interleukin-6-deficient, mice resist peripheral infection with scrapie. J Virol 2000, 74:3338-3344. 10.1128/JVI.74.7.3338-3344.2000, 111835, 10708451.
31. Tribouillard-Tanvier D, Race B, Striebel JF, Carroll JA, Phillips K, Chesebro B. Early cytokine elevation, PrPres deposition, and gliosis in mouse scrapie: no effect on disease by deletion of cytokine genes IL-12p40 and IL-12p35. J Virol 2012, 86:10377-10383. 10.1128/JVI.01340-12, 3457249, 22787236.
32. Khandelwal PJ, Herman AM, Moussa CE. Inflammation in the early stages of neurodegenerative pathology. J Neuroimmunol 2011, 238:1-11. 10.1016/j.jneuroim.2011.07.002, 3176984, 21820744.
33. Fratini F, Principe S, Puopolo M, Ladogana A, Poleggi A, Piscopo P, Bruno G, Castrechini S, Pascone R, Confaloni A, Minghetti L, Cardone F, Pocchiari M, Crescenzi M. Increased levels of acute-phase inflammatory proteins in plasma of patients with sporadic CJD. Neurology 2012, 79:1012-1018. 10.1212/WNL.0b013e318265a55d, 22855863.
34. Chen C, Xiao D, Zhou W, Shi Q, Zhang HF, Zhang J, Tian C, Zhang JZ, Dong XP. Global protein differential expression profiling of cerebrospinal fluid samples pooled from Chinese sporadic CJD and non-CJD patients. Mol Neurobiol 2013, doi: 10.1007/s12035-013-8519-2.